Research Article Details

Article ID: A41230
PMID: 630530
Source: Cancer
Title: Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisolone.
Abstract: Fifty patients with metastatic breast cancer were treated with a combination of vincristine, Adriamycin and prednisolone (VAP) at four weekly intervals. Response rates of 78% for soft tissue disease, 66% for parenchymal lung disease, 67% for liver disease, and 64% for pleural effusions were seen. Only 26% of patients with bone metastases showed an objective response. These figures are as good as any previously reported for chemotherapy of breast cancer.
DOI: 10.1002/1097-0142(197802)41:2<396::aid-cncr2820410203>3.0.co;2-t